CLASS C CONTROLLED DRUGS

PART 1

CANNABIS FRUIT.

CANNABIS PLANT [(whether fresh, dried, or otherwise)]—That is, any part of any plant of the genus Cannabis except a part from which all the resin has been extracted.

CANNABIS SEED.

[CATHA EDULIS PLANT.]

COCA LEAF—That is, the leaf of any plant of any species of the genus Erythroxylon, except a leaf from which all ecgonine, cocaine, and any other ecgonine alkaloids have been removed.

PART 2

CODEINE (3-methylmorphine); its isomers, esters, and ethers, if any; its salts, and the salts of its isomers, esters, or ethers, if any; and any substance, preparation or mixture containing any proportion of the said substance or of any such isomer, ester, ether, or salt, other than a preparation or mixture named or described in Part 6 of this Schedule.

DIHYDROCODEINE; its isomers, esters, and ethers, if any; its salts, and the salts of its isomers, esters, or ethers, if any; and any substance, preparation, or mixture containing any proportion of the said substance or of any such isomer, ester, ether, or salt, other than a preparation or mixture named or described in [[Part 6]] of this Schedule.]

[PROPOXYPHENE (a-4 (N, N-dimethylamino)-1, 2-diphenyl-3-methyl-2-propionoxybutane); its isomers, esters, and ethers, if any; its salts and the salts of its isomers, esters, or ethers, if any; except in preparations of propoxyphene described in clause 5A of Part 5 of this Schedule.]

PART 3

1.The following substances, namely:

ACETYLDIHYDROCODEINE.

. . . . . ETHYLMORPHINE (3-ethylmorphine).

NICOCODINE (6-nicotinylcodeine).

NICODICODINE (6-nicotinyldihydrocodeine or nicotinic acid ester of dihydrocodeine.

NORCODEINE (N -demethylcodeine).

PHOLCODINE (morpholinylethylmorphine).

PROPIRAM (N -(1-methyl-2-piperidinoethyl)-N -2-pyridylpropionamide).

2.The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the specific chemical designation.

3.The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and the ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.

4.The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.

5.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule, other than a preparation or mixture named or described in Part 6 of this Schedule.

[6.Preparations of pseudoephedrine, its salts, isomers, esters, and ethers (if any), and the salts of its isomers, esters, and ethers (if any), being preparations—

(a)in solid or liquid form; and

(b)containing not more than 60 mg of pseudoephedrine per dosage unit; and

(c)containing either a single ingredient or being in combination with other pharmacologically active ingredients, being ingredients that are not named or described in Schedule 1 or 2 or in Parts 1, 2, 4, or 5 of this schedule.]

PART 4

1.The following substances, namely:

[ALLOBARBITAL (5,5-diallylbarbituric acid).]

AMOBARBITAL (5-ethyl-5-(3-methylbutyl) barbituric acid).

[BUPRENORPHINE (17-cyclopropylmethyl-7,8-dihydro-7-(1-hydroxy-1,2, 2-trimethylpropyl) -6-0-methyl-6, 14-ethano-17-normorphine).]

[BUTALBITAL (5-allyl-5-isobutylbarbituric acid).]

BUTOBARBITONE (5-butyl-5-ethylbarbituric acid).

CYCLOBARBITAL (5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid).

GLUTETHIMIDE (2-ethyl-2-phenylglutarimide).

NEALBARBITONE (5-allyl-5-neopentylbarbituric acid).

PENTOBARBITAL (5-ethyl-5-(1-methylbutyl) barbituric acid).

[SECBUTABARBITAL (5-sec-butyl-5-ethylbarbituric acid).]

SECOBARBITAL (5-allyl-5-(1-methylbutyl) barbituric acid).

[VINYLBITAL (5-(1-methylbutyl)-5-vinylbarbituric acid).]

2.The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the specific chemical designation.

3.The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and the ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.

4.The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.

5.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4 of this Part of this Schedule[, except a mixture of a derivative of barbituric acid named or described in clause 1 of this Part of this Schedule compounded with one or more other pharmacologically active ingredients not named or described in clause 1 of this Part of this Schedule].

PART 5

1.The following substances, namely:

[ALPRAZOLAM.]

AMFEPRAMONE (2-(diethylamino) propiophenone).

[AMINOREX.]

BARBITAL (5,5-diethylbarbituric acid).

[BROMAZEPAM.]

[BROTIZOLAM.]

[CAMAZEPAM.]

[CHLORDIAZEPOXIDE.]

[CLOBAZAM.]

[CLONAZEPAM.]

[CLORAZEPATE.]

[CLOTIAZEPAM.]

[CLOXAZOLAM.]

[DELORAZEPAM.]

[DIAZEPAM.]

[EPHEDRINE.]

[ESTAZOLAM.]

ETHCHLORVYNOL (ethyl-2-chlorovinylethynyl-carbinol).

ETHINAMATE (1-ethynylcyclohexanol carbamate).

[ETHYL LOFLAZEPATE.]

[FLUDIAZEPAM.]

[FLUNITRAZEPAM.]

[FLURAZEPAM.]

[HALAZEPAM.]

[HALOXAZOLAM.]

[KETAZOLAM.]

[LOPRAZOLAM.]

[LORAZEPAM.]

[LORMETAZEPAM.]

MAZINDOL (5-(4-chlorophenyl)-2, 5-dihydro-3H-imidazo [2, 1-a]-isoindol-5-ol).]

[MEDAZEPAM.]

MEPROBAMATE (2-methyl-2-propyl-1,3-propanediol dicarbamate).

METHYLPHENOBARBITAL (5-ethyl-1-methyl-5-phenylbarbituric acid).

METHYLPRYLON (3,3-diethyl-5-methylpiperidine-2,4-dione).

[MIDAZOLAM.]

[NIMETAZEPAM.]

[NITRAZEPAM.]

[NORDAZEPAM.]

[OXAZEPAM.]

[OXAZOLAM.]

[PEMOLINE.]

PHENOBARBITAL (5-ethyl-5-phenylbarbituric acid).

[PHENTERMINE (2-amino-2-methyl-1-phenylpropane).]

[PINAZEPAM.]

PIPRADROL (1,1-diphenyl-1-(2-piperidyl)methanol).

[PRAZEPAM.]

[PSEUDOEPHEDRINE (other than a preparation referred to in clause 6 of Part 3 of this schedule).]

SPA ((-)-1-dimethylamino-1,2-diphenylethane).

[TEMAZEPAM.]

[TETRAZEPAM.]

[TRIAZOLAM.]

2.The isomers of the substances mentioned in this Part of this Schedule whenever the existence of such isomers is possible within the specific chemical designation.

3.The esters and ethers of the substances mentioned in this Part of this Schedule and the esters and the ethers of the isomers mentioned in clause 2 of this Part of this Schedule whenever the existence of such esters or ethers is possible.

4.The salts of the substances mentioned in this Part of this Schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3 of this Part of this Schedule.

[5.Mixtures of a derivative of barbituric acid named or described in Part 4 of this Schedule compounded with one or more other pharmacologically active ingredients not named or described in Part 4 of this Schedule.]

[5A.Preparations of propoxyphene, its isomers, esters, and ethers, if any, its salts, and the salts of its isomers, esters, or ethers, if any, for oral use containing not more than the equivalent of 135 milligrams of propoxyphene base per dosage unit or with a concentration of not more than 2.5 percent in undivided preparations, being preparations whereof none of the other ingredients is a substance named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule.]

[6.Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, clause 4, [[clause 5 or clause 5A]] of this Part of this Schedule, other than a preparation or mixture named or described in Part 6 of this Schedule.]

PART 6

The following substances, namely:

(a)Preparations containing any proportion of the following substances or of any salt of any such substance, namely, acetyldihydrocodeine, codeine, dihydrocodeine, ethylmorphine, and pholcodine when:

(i)Compounded with one or more other pharmacologically active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield which would constitute a risk to health; and

(ii)Containing not more than 100 milligrams of the substance in each dosage unit and with a concentration of not more than 2.5 percent in undivided preparations:

[(aa)Preparations containing a derivative of barbituric acid named or described in Part 4 or Part 5 of this Schedule, in solutions containing not more than 0.5 percent of that derivative of barbituric acid:]

(b)Preparations of cocaine containing not more than 0.1 percent of cocaine base, being preparations compounded with one or more other pharmacologically active ingredients (none of which are substances named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule ) in such a way that the preparation has no, or a negligible, risk of abuse, and in such a way that the cocaine cannot be recovered by readily applicable means or in a yield which would constitute a risk to health:

(c)Preparations of difenoxin containing, per dosage unit, not more than 0.5mg of difenoxin and a quantity of atropine sulphate equivalent to at least 5 percent of the dose of difenoxin:

(d)Preparations of opium or morphine containing not more than 0.2 percent of morphine, being preparations compounded with one or more other pharmacologically active ingredients (none of which are substances named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule ) in such a way that the opium or the morphine, as the case may be, cannot be recovered by readily applicable means or in a yield which would constitute a risk to health:

(e)Single dosage units of diphenoxylate containing in each unit not more than 2.5 milligrams of diphenoxylate calculated as base and not less than 25 micrograms of atropine sulphate:

(f)Liquid preparations of diphenoxylate containing, in each millilitre, not more than 0.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atroprine sulphate:

[(ff)Preparations of propiram containing not more than 100 mg of propiram per dosage unit and compounded with at least the same amount of methylcellulose:]

(g)Ipecacuanha and opium powder containing 10 percent of opium in powder and 10 percent of ipecacuanha root in powder intimately mixed with finely powdered lactose:

(h)Mixtures containing not more than one of the preparations specified in paragraphs (a) to (g) of this Part of this Schedule, being mixtures whereof none of the other ingredients is a substance named or described in Schedules 1 or 2 to this Act or in Parts 1 to 5 of this Schedule.

[PART 7

AMPHETAMINE ANALOGUES, in which the 1-amino-2-phenylethane nucleus carries any of the following radicals, either alone or in combination:

(a)1 or 2 alkyl radicals, each with up to 6 carbon atoms, attached to the nitrogen atom:

(b)1 or 2 methyl radicals, or an ethyl radical, attached to the carbon atom adjacent to the nitrogen atom:

(c)A hydroxy radical, attached to the carbon atom adjacent to the benzene ring:

(d)Any combination of up to 5 alkyl radicals and/or alkoxy radicals and/or alkylamino radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals and/or nitro radicals and/or amino radicals, attached to the benzene ring.

PETHIDINE ANALOGUES, in which a 4-phenylpiperidine nucleus carries any of the following radicals, either alone or in combination:

(a)An alkyl radical, with up to 6 carbon atoms, attached to the nitrogen atom:

(b)A phenalkyl radical, with up to 12 carbon atoms, attached to the nitrogen atom:

(c)A phenalkyl radical, as in paragraph (b), with 1 or more alkyl radicals, each with up to 6 carbon atoms, attached to the benzene ring in the phenalkyl radical:

(d)An alkylcarbonyloxy or alkoxycarbonyl or hydroxy radical, with up to 6 carbon atoms, attached to the 4 position in the piperidine ring:

(e)Any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to the benzene ring.

PHENCYCLIDINE ANALOGUES, being chemical compounds with the 1-alkylamino-1-arylcyclohexane structure, with any combination of the following alkylamino and aryl radicals:

(a)The alkylamino radical is 1-piperidinyl, 1-pyrrolidinyl, 4-morpholinyl, or any other radical with up to 6 carbon atoms in the alkyl portion:

(b)The aryl radical is phenyl, thienyl, pyridinyl, or pyrrolidinyl:

(c)The aryl radical, as described in paragraph (b), carries any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals.

FENTANYL ANALOGUES, in which the N-[1-(2-phenethyl)-4-piperidyl]aniline nucleus has additional radicals, either alone or in combination, attached as follows:

(a)An acetyl, propionyl, butenoyl or butanoyl radical, attached to the aniline nitrogen atom:

(b)One or more alkyl radicals, with up to 10 carbon atoms in total, attached to the ethyl moeity:

(c)Any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) [[and/or halogen radicals,]] attached to each of the benzene rings.

METHAQUALONE ANALOGUES, in which the 3-arylquinazolin-4-one nucleus has additional radicals, either alone or in combination, attached as follows:

(a)An alkyl radical, with up to 6 carbon atoms, attached at the two position:

(b)Any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to each of the aryl rings.

DMT (DIMETHYLTRYPTAMINE) ANALOGUES, in which the 3-(2-aminoethyl)indole nucleus has additional radicals, either alone or in combination, attached as follows:

(a)1 or 2 alkyl radicals, each with up to 6 carbon atoms, including cyclic radicals, attached to the amino nitrogen atom:

(b)1 or 2 methyl groups, or an ethyl group, attached to the carbon atom adjacent to the amino nitrogen atom:

(c)Any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to the benzene ring.]

Provided for advisory purposes only - some amendments may have been made subsequent to this. See www.legislation.govt.nz for the most up-to-date version of the Misuse of Drugs Act.

Unless stated otherwise, copyright © 1998-2005 by NORML New Zealand: working for marijuana law reform

Published on: 2006-03-23 (10766 reads)